Swiss Re appoints former Allianz Re CEO to board

Swiss Re has proposed several changes to its board of directors, including the appointment of a former CEO of Allianz Re and the former chairman of Novartis. The appointments will be formally made at its annual general meeting of shareholders on 21 April 2017.

Jay Ralph was most recently a member of the board of management of Allianz and chairman at Allianz Asset Management. His prior roles at Allianz include CEO of Allianz Re and CEO of Allianz Risk Transfer. He started his career at Arthur Andersen & Company and also worked for Centre Re Bermuda before joining Allianz.

Joerg Reinhardt has been the chairman of the board of directors of Novartis since 2013. Previously, he was chairman of the board of management and the executive committee of Bayer HealthCare, Germany. He was also a member of the supervisory board of MorphoSys in Germany and a member of the board of Lonza Group in Switzerland.

Swiss Re had already indicated that it also proposes to elect Jacques de Vaucleroy to its board of directors. Carlos Represas, who has been a member of Swiss Re's board since 2010, will not stand for re-election.

Today’s top stories

Profits tumble at Swiss Re yet growth surges

Greenlight Re heads back into profit as it resolves legacy issues

CFO of XL Group to retire; successor revealed

Alleghany enjoys solid growth but headwinds dent profits

Swiss Re group CUO quits to ‘start new chapter in life’

Did you enjoy reading this story?  Sign up to our free daily newsletters and get stories like this sent straight to your inbox.